4.3 Letter

The simplified mantle cell lymphoma international prognostic index predicts overall survival but not progression-free survival in patients with mantle cell lymphoma treated with fludarabine and cyclophosphamide +/- rituximab: results of a randomized phase II trial

Journal

LEUKEMIA & LYMPHOMA
Volume 50, Issue 10, Pages 1709-1711

Publisher

TAYLOR & FRANCIS LTD
DOI: 10.1080/10428190903186494

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available